Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
出版年份 2019 全文链接
标题
Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides
作者
关键词
Afatinib, Epidermal growth factor receptor (EGFR), Nanoparticles, Cell-penetrating peptides, Colorectal cancer, Targeting delivery
出版物
JOURNAL OF NANOBIOTECHNOLOGY
Volume 17, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-08-19
DOI
10.1186/s12951-019-0519-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
- (2019) Said Abdullah Khelwatty et al. Oncotarget
- Tacrolimus-loaded methoxy poly(ethylene glycol)-block-poly(D,L)-lactic–co-glycolic acid micelles self-assembled in aqueous solution for treating cornea immune rejection after allogenic penetrating keratoplasty in rats
- (2019) Dong Liu et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Tyrosine Kinase Inhibitor Gold Nanoconjugates for the Treatment of Non-Small Cell Lung Cancer
- (2019) Alexander M. Cryer et al. ACS Applied Materials & Interfaces
- Investigation of PLGA nanoparticles in conjunction with nuclear localization sequence for enhanced delivery of antimiR phosphorothioates in cancer cells in vitro
- (2019) Shipra Malik et al. JOURNAL OF NANOBIOTECHNOLOGY
- The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles
- (2018) Xiu-Chai Zheng et al. International Journal of Nanomedicine
- Anti epidermal growth factor receptor therapy in small bowel adenocarcinoma
- (2018) Rosa Falcone et al. MEDICINE
- Drug resistance and new therapies in colorectal cancer
- (2018) Kevin Van der Jeught et al. WORLD JOURNAL OF GASTROENTEROLOGY
- A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo
- (2018) Amirhossein Bahreyni et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Evaluation of the drug loading capacity of different lipid nanoparticle dispersions by passive drug loading
- (2017) Karin M. Rosenblatt et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- High drug-loading nanomedicines: progress, current status, and prospects
- (2017) Shihong Shen et al. International Journal of Nanomedicine
- Afatinib Decreases P-Glycoprotein Expression to Promote Adriamycin Toxicity of A549T Cells
- (2017) Yan Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer
- (2017) Masao Ichiki et al. OncoTargets and Therapy
- Recent developments in the treatment of metastatic colorectal cancer
- (2017) Jonathan M. Loree et al. Therapeutic Advances in Medical Oncology
- Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer
- (2016) Fangyuan Zou et al. FEBS Journal
- Global patterns and trends in colorectal cancer incidence and mortality
- (2016) Melina Arnold et al. GUT
- miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1
- (2016) Heyong Liu et al. PATHOLOGY RESEARCH AND PRACTICE
- HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives
- (2016) Valentina Fanotto et al. Oncotarget
- miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2
- (2016) Qingguo Li et al. Scientific Reports
- Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib
- (2015) Vera Hirsh BIODRUGS
- Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers
- (2015) Said A Khelwatty et al. BRITISH JOURNAL OF CANCER
- Functionalized gold nanoparticles improve afatinib delivery into cancer cells
- (2015) Sílvia Castro Coelho et al. Expert Opinion on Drug Delivery
- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
- (2015) James Chih-Hsin Yang et al. LANCET ONCOLOGY
- HER2 Activating Mutations Are Targets for Colorectal Cancer Treatment
- (2015) S. M. Kavuri et al. Cancer Discovery
- The pan-HER family tyrosine kinase inhibitor afatinib overcomes HER3 ligand heregulin-mediated resistance to EGFR inhibitors in non-small cell lung cancer
- (2015) Kimio Yonesaka et al. Oncotarget
- Afatinib and its encapsulated polymeric micelles inhibits HER2-overexpressed colorectal tumor cell growth in vitro and in vivo
- (2015) Siao-Syun Guan et al. Oncotarget
- Neuropilin regulation of angiogenesis: Figure 1
- (2014) Anastasia Lampropoulou et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Afatinib in the treatment of breast cancer
- (2014) Sara A Hurvitz et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Intravenously administered nanoparticles increase survival following blast trauma
- (2014) M. M. Lashof-Sullivan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A review
- (2013) Kunn Hadinoto et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Prognostic significance and targeting of HER family in colorectal cancer
- (2013) Helmout Modjtahedi Frontiers in Bioscience-Landmark
- Caspase Functions in Cell Death and Disease
- (2013) D. R. McIlwain et al. Cold Spring Harbor Perspectives in Biology
- Tumor-Penetrating Peptides
- (2013) Tambet Teesalu et al. Frontiers in Oncology
- MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor
- (2012) Ke Shen et al. BIOCHEMICAL PHARMACOLOGY
- Moonlighting Peptides with Emerging Function
- (2012) Jonathan G. Rodríguez Plaza et al. PLoS One
- The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel
- (2011) Bing-Xiang Zhao et al. BIOMATERIALS
- HER2 Interacts With CD44 to Up-regulate CXCR4 via Epigenetic Silencing of microRNA-139 in Gastric Cancer Cells
- (2011) Wei Bao et al. GASTROENTEROLOGY
- The pH sensitivity of histidine-contain- ing lytic peptides
- (2009) Zhigang Tu et al. JOURNAL OF PEPTIDE SCIENCE
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform
- (2008) Liangfang Zhang et al. ACS Nano
- Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles
- (2008) ShuYu Xie et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Studies on anticancer activities of antimicrobial peptides
- (2007) David W. Hoskin et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now